MEDICINES
Professor Mike Scott, Director MOIC pictured with Dr Glenda Fleming, Deputy Director.
OUTSTANDING GLOBAL ACHIEVEMENT
NORTHERN IRELAND’S PROWESS IN THE FIELD OF MEDICINES OPTIMISATION IS ENHANCING OUR REPUTATION NOT ONLY NATIONALLY, BUT GLOBALLY. PIF RECENTLY VISITED THE MEDICINES OPTIMISATION INNOVATION CENTRE (MOIC) IN ANTRIM TO SPEAK TO PROFESSOR MIKE
T
here’s no doubt that the safe and effective use of medicines - not to mention medicines
expenditure - have all come under the spotlight over the last decade.
From a financial aspect, medicines expenditure equates to over £550m/annum in Northern Ireland, representing fourteen per cent of the total Health and Social Care (HSC) budget and making it the second largest cost after salaries.
As the population ages and the prevalence of chronic disease is expected to rise, direct pressure will be placed on prescribing budgets and will lead to an increased demand across HSC services, particularly those involved with the prescribing, dispensing and administration of medicines.
10 - PHARMACY IN FOCUS
With many years of expertise in developing good practice in the area of Pharmaceutical Care and Medicines Management, Northern Ireland was recognised in 2013 as one of the leading regions in Europe with three-star reference site status for medicines management and we’ve recently submitted an application to the European Innovation Partnership for Active and Healthy Aging with an ambition of achieving four-star status.
Despite the province’s success, the increasing complexity of medication regimens, and the increase in numbers of older citizens with co-morbidities means there is still room for improvement. For that reason, Professor Scott and his team developed a new approach to managing and ensuring the cost- effective use of medicine expenditure,
which subsequently led to the launch of the Medicines Optimisation Innovation Centre (MOIC) in October 2015. Since then, the centre has won a series of early successes both at home and on the international stage.
‘Historically,’ Professor Scott told PiF, ‘the approach taken to reduce medicines expenditure has been to focus almost exclusively on costs and cost-cutting initiatives. This methodology has had only limited success, as it fails to address the more fundamental aspects of the quality and safety of medicine use. Hence, in Northern Ireland a new strategy was adopted, based on the premise that quality and safety drive health gain and economy.
“The MOIC as a key part of, the Medicines Optimisation Quality
NORTHERN IRELAND’S PROWESS IN THE FIELD OF MEDICINES OPTIMISATION IS ENHANCING OUR REPUTATION NOT ONLY NATIONALLY, BUT GLOBALLY. PIF RECENTLY VISITED THE MEDICINES OPTIMISATION INNOVATION CENTRE (MOIC) IN ANTRIM TO SPEAK TO PROFESSOR MIKE SCOTT ABOUT HOW MUCH HAS BEEN ACHIEVED...
Framework effectively acts as a ‘front door’ for anyone wanting to work with medicines to improve patient care and to work with enabling technologies.’
‘The Framework aims to support both patient care and the transformation of the HSC system by helping to deliver:
• better health outcomes for patients through the appropriate use of medicines, taken as prescribed
• better informed patients who are engaged and involved in decisions about their medicines
• improved medicines safety at transitions of care
• an active medicines safety culture within HSC organisations
• reduced variance in medicines use
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64